Table 3.

Down‐regulation of miR‐205 and up‐regulation of AR expression decrease the MAP, ICP and ICP/MAP value

Group	Number	MAP (mm Hg)	ICP (mm Hg)	ICP/MAP
Normal	10	112.93 ± 10.28	98.45 ± 9.82	0.88 ± 0.12
DMED	10	89.32 ± 7.45a	27.46 ± 3.41a	0.31 ± 0.06a
NC	10	91.62 ± 8.69a	26.75 ± 2.61a	0.3 ± 0.03a
miR‐205 mimic	10	89.57 ± 7.26a, b	19.68 ± 0.83a, b	0.22 ± 0.02a, b
miR‐205 inhibitor	10	129.49 ± 9.65a, b	62.34 ± 5.66a, b	0.49 ± 0.07a, b
AR overexpression	10	132.81 ± 10.73a, b	61.62 ± 6.52a, b	0.46 ± 0.03a, b
miR‐205 mimic +AR overexpression	10	87.46 ± 8.28a	26.98 ± 2.46a	0.31 ± 0.04a

AR, androgen receptor; DMED, erectile dysfunction rats with diabetic mellitus; miR‐205, microRNA‐205; NC, negative control.

The level of MAP, ICP and ICP/MAP were measurement data, which was expressed as mean ± SD; data in each group was analysed with ANOVA; the sample size of each group was 10; the experiment was repeated for three times.

^a P < 0.05 vs. the normal group.

^b P < 0.05 vs. the DMED group and the NC group.